Ad
related to: statistically significant
Search results
Earnings call: INOVIO outlines 2024 plans, reports Q1 financials By Investing.com
Investing.com· 2 hours agoINOVIO Pharmaceuticals Inc. (NASDAQ: INO), a biotechnology company, has reported its financial...
Novo Nordisk's Hemophilia Candidate Can Prevent Bleeding Episodes Effectively, Regardless Of Dosing...
Benzinga via Yahoo Finance· 15 hours agoRead Next: Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy...
...Adoption: Uniswap Interface Reportedly Provides Statistically Significant Price Improvements Over...
Crowdfund Insider· 14 hours agoResearch from Uniswap Labs proposes a new methodology for measuring price improvements across Order...
Novo Nordisk shares positive results from Phase IIIa trial of haemophilia A drug
Clinical Trials Arena via Yahoo Finance· 3 hours agoIt compared the safety and efficacy of once-weekly and once-monthly subcutaneous doses of Mim8...
Merck cancels trial of melanoma treatment due to immune-mediated adverse events
Clinical Trials Arena via Yahoo Finance· 2 hours agoMSD attributed the discontinuation mainly to immune-mediated adverse events, which made it 'highly...
Facebook Use May Have Raised Trump Chances in 2020, Report Shows
Bloomberg· 16 hours agoUsing Facebook in the lead-up to the US 2020 presidential election might have increased the chances...
The suicide crisis among young Black and Latino Chicagoans demands action
Chicago Sun-Times· 23 minutes agoWhile many people in Chicago face challenges to their mental health, some groups have been impacted...
Cardurion’s PDE9 inhibitor increases cGMP in Phase IIa heart failure trial
Clinical Trials Arena via Yahoo Finance· 1 day agoThe CARDINAL-HF Phase IIa trial (NCT05409183), CRD-740 met the primary endpoint in heart failure...
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 4 days ago-- Statistically significant week 96 results from the Phase 2b HARMONY study of EFX in patients with pre-cirrhotic MASH reported during the first quarter ...
Calliditas announces positive topline results of phase 2 head and neck cancer trial
BioPharma-Reporter· 5 days agoThe analysis showed statistically significant improvements in progression-free survival (PFS), as...
